| First Author | Chen L | Year | 2021 |
| Journal | Sci Rep | Volume | 11 |
| Issue | 1 | Pages | 12890 |
| PubMed ID | 34145375 | Mgi Jnum | J:322021 |
| Mgi Id | MGI:6720168 | Doi | 10.1038/s41598-021-92369-8 |
| Citation | Chen L, et al. (2021) Overexpression of ferroptosis defense enzyme Gpx4 retards motor neuron disease of SOD1G93A mice. Sci Rep 11(1):12890 |
| abstractText | Degeneration and death of motor neurons in Amyotrophic Lateral Sclerosis (ALS) are associated with increased lipid peroxidation. Lipid peroxidation is the driver of ferroptosis, an iron-dependent oxidative mode of cell death. However, the importance of ferroptosis in motor neuron degeneration of ALS remains unclear. Glutathione peroxidase 4 (Gpx4) is a key enzyme in suppressing ferroptosis by reducing phospholipid hydroperoxides in membranes. To assess the effect of increased protection against ferroptosis on motor neuron disease, we generated SOD1(G93A)GPX4 double transgenic mice by cross-breeding GPX4 transgenic mice with SOD1(G93A) mice, a widely used ALS mouse model. Compared with control SOD1(G93A) mice, both male and female SOD1(G93A)GPX4 mice had extended lifespans. SOD1(G93A)GPX4 mice also showed delayed disease onset and increased motor function, which were correlated with ameliorated spinal motor neuron degeneration and reduced lipid peroxidation. Moreover, cell toxicity induced by SOD1(G93A) was ameliorated by Gpx4 overexpression and by chemical inhibitors of ferroptosis in vitro. We further found that the anti-ferroptosis defense system in spinal cord tissues of symptomatic SOD1(G93A) mice and sporadic ALS patients might be compromised due to deficiency of Gpx4. Thus, our results suggest that ferroptosis plays a key role in motor neuron degeneration of ALS. |
